Skip to Main Content

Teladoc’s blockbuster merger with Livongo in 2020 would’ve been unthinkable just a few years ago.

Health technology companies didn’t typically command enormous valuations, and they certainly didn’t sell for $18.5 billion.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment